Literature DB >> 1317612

Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five years.

J Yamamoto1, T Kosuge, T Takayama, K Shimada, M Makuuchi, J Yoshida, M Sakamoto, S Hirohashi, S Yamasaki, H Hasegawa.   

Abstract

BACKGROUND: To find the rational surgical strategy for the treatment of intrahepatic cholangiocarcinoma (ICC), clinical features of ICC were studied in 20 patients who underwent hepatic resection in the National Cancer Center Hospital from 1980 to 1990.
METHODS: According to the morphologic pattern, we classified the ICCs into two subcategories, mass-forming and infiltrating, which correlated with their biologic behavior.
RESULTS: Of 10 patients who underwent hepatectomy for mass-forming ICC, three survived more than 5 years without recurrence. The 1-, 3-, and 5-year survival rates were 59.3%, 44.4%, and 44.4%, respectively. Of 10 patients who underwent hepatectomy for infiltrating ICC, one survived more than 5 years without recurrence. The 1-, 3-, and 5-year survival rates were 72.0%, 27.0%, and 27.0%, respectively. The pathologic findings and recurrences indicated that the salient feature of the mass-forming type was its tendency for intrahepatic metastasis especially near a main lesion, and of the infiltrating type was the infiltrative spread via Glisson's capsule and hilar lymph nodal metastasis.
CONCLUSIONS: An anatomic and extensive liver resection should be performed for mass-forming ICC, whereas a hepatectomy with excision of the extrahepatic bile duct and hilar lymph nodal dissection is recommended for infiltrating ICC.

Entities:  

Mesh:

Year:  1992        PMID: 1317612

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  19 in total

1.  Intrahepatic cholangiocarcinoma.

Authors:  Kimberly M Brown; Abhishek D Parmar; David A Geller
Journal:  Surg Oncol Clin N Am       Date:  2014-04       Impact factor: 3.495

2.  Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.

Authors:  Shiro Miwa; Shinichi Miyagawa; Akira Kobayashi; Yasuhiko Akahane; Takenari Nakata; Motohiro Mihara; Kei Kusama; Junpei Soeda; Shinichiro Ogawa
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

3.  Intrahepatic Biliary Intraductal Oncocytic Papillary Neoplasm/Carcinoma: First Reported Case in Australia and Literature Review.

Authors:  Christopher Chu; William Felbel; Francis Chu
Journal:  Radiol Case Rep       Date:  2015-12-07

4.  Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver.

Authors:  A Tannapfel; L Weinans; F Geissler; A Schütz; A Katalinic; F Köckerling; J Hauss; C Wittekind
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

5.  Surgery and chemotherapy for intrahepatic cholangiocarcinoma.

Authors:  Zenichi Morise; Atsushi Sugioka; Takamasa Tokoro; Yoshinao Tanahashi; Yasuhiro Okabe; Tadashi Kagawa; Chinatsu Takeura
Journal:  World J Hepatol       Date:  2010-02-27

6.  Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases.

Authors:  J R Madariaga; S Iwatsuki; S Todo; R G Lee; W Irish; T E Starzl
Journal:  Ann Surg       Date:  1998-01       Impact factor: 12.969

7.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

8.  Gross pathological classification of peripheral cholangiocarcinoma determines the efficacy of hepatectomy.

Authors:  Chun-Nan Yeh; Ta-Sen Yeh; Tse-Ching Chen; Yi-Yin Jan; Miin-Fu Chen
Journal:  J Gastroenterol       Date:  2012-09-25       Impact factor: 7.527

9.  Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma.

Authors:  Shohachi Suzuki; Takanori Sakaguchi; Yoshihiro Yokoi; Kazuya Okamoto; Kiyotaka Kurachi; Yasuo Tsuchiya; Takuya Okumura; Hiroyuki Konno; Satoshi Baba; Satoshi Nakamura
Journal:  World J Surg       Date:  2002-03-26       Impact factor: 3.352

10.  Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer.

Authors:  J Yamamoto; K Sugihara; T Kosuge; T Takayama; K Shimada; S Yamasaki; M Sakamoto; S Hirohashi
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.